Zoetis (ZTS) Non-Current Debt (2013 - 2026)
Zoetis' (ZTS) quarterly Non-Current Debt came in at $9.0 billion in Q2 2026, up 72.97% year-over-year from $5.2 billion in Q2 2025, and little changed quarter-over-quarter from $9.0 billion in Q1 2026.
Analysis
Zoetis (ZTS) Non-Current Debt (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Non-Current Debt for 14 consecutive years, with $9.0 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt rose 72.97% year-over-year to $9.0 billion in Q2 2026; TTM through Jun 2026 was $9.0 billion, a 72.97% increase from a year earlier, with the FY2025 full-year figure at $9.0 billion, up 73.22% from the prior year.
- Non-Current Debt was $9.0 billion for Q2 2026 at Zoetis, roughly flat from $9.0 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $9.0 billion in Q2 2026 and troughed at $5.2 billion in Q3 2022.
- A 5-year average of $6.6 billion and a median of $6.6 billion in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt slipped 20.96% in 2022 and jumped 73.22% in 2025, its largest moves.
- Over 5 years, Non-Current Debt stood at $6.6 billion in 2022, then grew by 0.18% to $6.6 billion in 2023, then declined by 20.48% to $5.2 billion in 2024, then jumped by 73.22% to $9.0 billion in 2025, then advanced by 0.07% to $9.0 billion in 2026.
- The last three Non-Current Debt figures came in at $9.0 billion (Q2 2026), $9.0 billion (Q1 2026), and $9.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.42 Bn | 40.22 Bn | 779.09 Mn | 299.87 Mn |
| 2 | Zoetis | 30.44 Bn | 28.76 Bn | 1.05 Bn | 9.05 Bn |
| 3 | Elanco Animal Health | 11.62 Bn | 11.09 Bn | 798.00 Mn | 3.85 Bn |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn | 591.77 Mn |
| 5 | Immucell | 90.01 Mn | 81.15 Mn | 2.44 Mn | 8.30 Mn |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | 1.25 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.05 Bn |
| Mar 31, 2026 | 9.05 Bn |
| Dec 31, 2025 | 9.04 Bn |
| Sep 30, 2025 | 7.07 Bn |
| Jun 30, 2025 | 5.23 Bn |
| Mar 31, 2025 | 5.23 Bn |
| Dec 31, 2024 | 5.22 Bn |
| Sep 30, 2024 | 6.57 Bn |
| Jun 30, 2024 | 6.56 Bn |
| Mar 31, 2024 | 6.56 Bn |
| Dec 31, 2023 | 6.56 Bn |
| Sep 30, 2023 | 6.55 Bn |
| Jun 30, 2023 | 6.56 Bn |
| Mar 31, 2023 | 6.56 Bn |
| Dec 31, 2022 | 6.55 Bn |
| Sep 30, 2022 | 5.21 Bn |
| Jun 30, 2022 | 5.22 Bn |
| Mar 31, 2022 | 5.23 Bn |
| Dec 31, 2021 | 6.59 Bn |
| Sep 30, 2021 | 6.59 Bn |